Evidence map›Paper›PMID 38988671›Full record

ReviewJournal of the Endocrine Society2024

Adipose Tissue Dysfunction and the Role of Adipocyte-Derived Extracellular Vesicles in Obesity and Metabolic Syndrome.

Alejandra Sandoval-Bórquez, Pablo Carrión, María Paz Hernández, Jorge A Pérez, Alejandra Tapia-Castillo, Andrea Vecchiola, Carlos E Fardella, Cristian A Carvajal

Abstract readReview
In one paragraph

Review in Journal of the Endocrine Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alejandra Sandoval-BórquezSchool of Medical Technology, Faculty of Science, Pontificia Universidad Católica de Valparaiso, Valparaiso 2373223, Chile.
Pablo CarriónCenter for Translational Research in Endocrinology (CETREN-UC), Pontificia Universidad Católica de Chile, Santiago 8330074, Chile.
María Paz HernándezCenter for Translational Research in Endocrinology (CETREN-UC), Pontificia Universidad Católica de Chile, Santiago 8330074, Chile.
Jorge A PérezCenter for Translational Research in Endocrinology (CETREN-UC), Pontificia Universidad Católica de Chile, Santiago 8330074, Chile.
Alejandra Tapia-CastilloCenter for Translational Research in Endocrinology (CETREN-UC), Pontificia Universidad Católica de Chile, Santiago 8330074, Chile.ORCID https://orcid.org/0000-0002-6081-1468
Andrea VecchiolaCenter for Translational Research in Endocrinology (CETREN-UC), Pontificia Universidad Católica de Chile, Santiago 8330074, Chile.
Carlos E FardellaCenter for Translational Research in Endocrinology (CETREN-UC), Pontificia Universidad Católica de Chile, Santiago 8330074, Chile.ORCID https://orcid.org/0000-0002-5500-4434
Cristian A CarvajalCenter for Translational Research in Endocrinology (CETREN-UC), Pontificia Universidad Católica de Chile, Santiago 8330074, Chile.ORCID https://orcid.org/0000-0002-0668-412X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity is a major public health issue that is associated with metabolic diseases including diabetes mellitus type 2 and metabolic syndrome. This pathology leads to detrimental cardiovascular health and secondary effects, such as lipotoxicity, inflammation, and oxidative stress. Recently, extracellular vesicles (EVs) have been highlighted as novel players participating in human physiology and pathophysiology. In obesity, adipose tissue is related to the active shedding of adipocyte-derived extracellular vesicles (AdEVs). The current review explores and highlights the role of AdEVs and their cargo in obesity and metabolic syndrome. AdEVs are proposed to play an important role in obesity and its comorbidities. AdEVs are biological nanoparticles mainly shed by visceral and subcutaneous adipose tissue, acting in physiological and pathophysiological conditions, and also carrying different cargo biomolecules, such as RNA, microRNA (miRNA), proteins, and lipids, among others. RNA and miRNA have local and systemic effects affecting gene expression in target cell types via paracrine and endocrine actions. State of the art analyses identified some miRNAs, such as miR-222, miR-23b, miR-4429, miR-148b, and miR-4269, that could potentially affect cell pathways involved in obesity-related comorbidities, such as chronic inflammation and fibrosis. Similarly, AdEVs-proteins (RBP4, perilipin-A, FABP, mimecan, TGFBI) and AdEVs-lipids (sphingolipids) have been linked to the obesity pathophysiology. The current knowledge about AdEVs along with further research would support and reveal novel pathways, potential biomarkers, and therapeutic options in obesity.

Indexed as

adipocyte-derived extracellular vesicles (AdEVs)metabolic syndromeobesity

Identifiers

PMID38988671
PMCPMC11234198

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.